Funding and Efficiency of The Malaria Program in Africa: Case Niger
Uitgelicht
|
48,90 |
Naar shop
|
|
48,90 |
Naar shop
|
|
48,90 |
Naar shop
|
Beschrijving
Bol
This is an economic evaluation of Niger's National Malaria Control Program (PNLP), conducted to identify the main components of the program's funding and determine the most efficient strategy(ies) among those implemented, thereby assisting in the selection of the most appropriate strategies and ensuring the sustainability of funding for the fight against malaria-the most significant disease in terms of morbidity in Niger-within a context of scarce resources. To this end, we collected and analyzed information on the resources mobilized under the various strategies, the target populations, the program's objectives, the results achieved by strategy, and their impacts. Based on these data, we calculated indicators of effectiveness and efficiency. We found that malaria costs Niger an average of nine million two hundred seventy thousand (9,270,000) U.S. dollars per year for treatment and prevention, excluding the direct costs associated with MILDA's free distribution campaigns. These costs are dominated by recurring expenses.
This is an economic evaluation of Niger's National Malaria Control Program (PNLP), conducted to identify the main components of the program's funding and determine the most efficient strategy(ies) among those implemented, thereby assisting in the selection of the most appropriate strategies and ensuring the sustainability of funding for the fight against malaria-the most significant disease in terms of morbidity in Niger-within a context of scarce resources. To this end, we collected and analyzed information on the resources mobilized under the various strategies, the target populations, the program's objectives, the results achieved by strategy, and their impacts. Based on these data, we calculated indicators of effectiveness and efficiency. We found that malaria costs Niger an average of nine million two hundred seventy thousand (9,270,000) U.S. dollars per year for treatment and prevention, excluding the direct costs associated with MILDA's free distribution campaigns. These costs are dominated by recurring expenses.
AmazonPagina's: 52, Paperback, Our Knowledge Publishing
Prijshistorie
* Prijshistorie bevat geen data van Amazon, Amazon Marketplace.
Prijzen voor het laatst bijgewerkt op: